Fenchone

Fenchone

SCHEMBL856607

CC1(C)C(=O)[C@@]2(C)CC[C@@H]1C2

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.38
ALDH1A1 P00352 1/20 0.38
LMNA P02545 1/20 0.38
MAPT P10636 1/20 0.38
KMT2A Q03164 1/20 0.38
TSHR P16473 1/20 0.37
P2RX7 Q99572 1/20 0.32
GPR84 Q9NQS5 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
(+)-Fenchone SCHEMBL856608 1.00 MEN1 (0.38) MEN1ALDH1A1LMNAMAPTKMT2A
(L)-Fenchone SCHEMBL18221219 1.00 MEN1 (0.38) MEN1ALDH1A1LMNAMAPTKMT2A
Fenchone SCHEMBL15047583 1.00 MEN1 (0.38) MEN1ALDH1A1LMNAMAPTKMT2A
Fenchone SCHEMBL527930 1.00 MEN1 (0.38) MEN1ALDH1A1LMNAMAPTKMT2A
(-)-Fenchone SCHEMBL7997210 1.00 MEN1 (0.38) MEN1ALDH1A1LMNAMAPTKMT2A
SCHEMBL19388309 0.87 TSHR (0.35) MEN1ALDH1A1LMNAMAPTKMT2A
SCHEMBL11802436 0.86 MAPT (0.40) MEN1ALDH1A1LMNAMAPTKMT2A
SCHEMBL4140998 0.80 MAPT (0.32) MAPT
SCHEMBL27818456 0.78 MEN1 (0.35) MEN1ALDH1A1LMNAMAPTKMT2A
SCHEMBL6623292 0.76 KMT2A (0.41) MEN1ALDH1A1LMNAMAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 267 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4257663-A1 FOOD CONTACT SURFACE SANITIZING LIQUID The Procter & Gamble Company (US) 2023-10-11 EP claimed
US-11424006-B2 Targeted drugs associated with trimethylamine and/or trimeihylamine-n-oxide PSOMAGEN, INC. (US) 2022-08-23 US claimed
US-20220112451-A1 BOURBON REPLICAS PRODUCED FROM INDIVIDUAL COMPONENTS AVA FOOD LABS, INC. 2022-04-14 US claimed
US-20220010248-A1 SCOTCH REPLICAS PRODUCED FROM INDIVIDUAL COMPONENTS AVA FOOD LABS, INC. 2022-01-13 US claimed
CN-113825409-A Whiskey imitation made from individual components 艾娃食品实验室有限公司 2021-12-21 CN claimed
US-20210340474-A1 WHISKEY REPLICAS PRODUCED FROM INDIVIDUAL COMPONENTS AVA FOOD LABS, INC. 2021-11-04 US claimed
EP-3860359-A1 WHISKEY REPLICAS PRODUCED FROM INDIVIDUAL COMPONENTS AVA FOOD LABS, INC. (US) 2021-08-11 EP claimed
EP-3860360-A1 SCOTCH REPLICAS PRODUCED FROM INDIVIDUAL COMPONENTS AVA FOOD LABS, INC. (US) 2021-08-11 EP claimed
US-20210128498-A1 TARGETED DRUGS ASSOCIATED WITH TRIMETHYLAMINE AND/OR TRIMETHYLAMINE-N-OXIDE MACROGEN INC. (KR) 2021-05-06 US claimed
EP-3755786-A1 ALCOHOLIC BEVERAGES PRODUCED FROM INDIVIDUAL COMPONENTS AVA FOOD LABS, INC. (US) 2020-12-30 EP claimed
CN-101346073-A Compositions providing a sensation substantially similar to that provided by menthol CADBURY ADAMS USA LLC (US) 2009-01-14 CN claimed
EP-1973421-A2 COMPOSITIONS PROVIDING A SENSATION SUBSTANTIALLY SIMILAR TO THAT PROVIDED BY MENTHOL Cadbury Adams USA LLC (US) 2008-10-01 EP claimed
CN-101011441-A Externally used medicine for vasculitis and varicosevein AN BANGTAO (CN) 2007-08-08 CN claimed
WO-2007076025-A2 COMPOSITIONS PROVIDING A SENSATION SUBSTANTIALLY SIMILAR TO THAT PROVIDED BY MENTHOL CADBURY ADAMS USA LLC (US) 2007-07-05 WO claimed
US-20070148283-A1 Compositions providing a sensation substantially similar to that provided by menthol CADBURY ADAMS USA LLC 2007-06-28 US claimed
EP-0806904-A4 1997-11-26 EP claimed
EP-0806904-A1 COMESTIBLES CONTAINING STABILIZED HIGHLY ODOROUS FLAVOR COMPONENT DELIVERY SYSTEMS FUISZ TECHNOLOGIES LTD. (US) 1997-11-19 EP claimed
US-5633027-A SOLID DELIVERY SYSTEM; MIXTURE OF FLAVORED OILS AND TRIGLYCERIDES FUISZ TECHNOLOGIES LTD. (US) 1997-05-27 US claimed
US-5556652-A CHEWING GUM, SOLID SUBSTRATE WITH ADSORBED FLAVOR OIL AND TRIGLYCERIDE FUISZ TECHNOLOGIES LTD. (US) 1996-09-17 US claimed
WO-1996003894-A1 COMESTIBLES CONTAINING STABILIZED HIGHLY ODOROUS FLAVOR COMPONENT DELIVERY SYSTEMS FUISZ TECHNOLOGIES LTD. (US) 1996-02-15 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11424006-B2 Targeted drugs associated with trimethylamine and/or trimeihylamine-n-oxide PNMT, MAOA, HNMT MEN1 1637/4885ALDH1A1 988/4885LMNA 2593/4885
US-20210128498-A1 TARGETED DRUGS ASSOCIATED WITH TRIMETHYLAMINE AND/OR TRIMETHYLAMINE-N-OXIDE MAOA, PNMT, HNMT MEN1 1092/4885ALDH1A1 959/4885LMNA 2828/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.